SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biocircuits BIOC
BIOC 0.435-13.1%Oct 24 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HeyRainier who wrote (18)6/6/1997 12:50:00 PM
From: Xingbo Wang   of 65
 
Thanks for pointing out the error in my post about analyst coverage. I had always thought they had no analyst coverage but did not know one analyst started it recently.

But I still consider BIOC's balance sheet as weak. The $0.58 cash per share is not enought for even two quarters at their current burn rate, so either their sales need to skyrocket right now as we speak, or they need further financing. Which one do you think is likely to happen?

Regards,

Xingbo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News